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Background: Kidney injuries provoke considerable adjustment of renal physiology, metabolism, and architecture to
nephron loss. Despite remarkable regenerative capacity of the renal tissue, these adaptations often lead to tubular
atrophy, interstial and glomerular scaring, and development of chronic kidney disease. The therapeutic strategies for
prevention of the transition from acute kidney damage to a chronic condition are limited. The purpose of this
study was to elucidate large-scale alterations of the renal cortex proteome in partially nephrecromized rats at an
early stage of chronic kidney disease.
Methods: Sprague–Dawley 5/6 nephrectomized rats and sham-operated controls were sacrificed at day 28
post-surgery. To identify proteins with notable alteration of expression we applied a 2D-proteomics approach
followed by mass-spectrometry. Altered expression of identified and related proteins was validated by Western
blotting and immunohistochemistry.
Results: Proteins with increased levels of expression after partial nephrectomy were albumin and vimentin. Proteins
with decreased expression were metabolic or mitochondrial. Western blotting analysis showed that the renal cortex
of nephrectomized rats expressed decreased amount (by ~50%) of proteins from the inner mitochondrial
compartment - the beta-oxidation enzyme MCAD, the structural protein GRP-75, and the oxidative phosphorylation
protein COXIV. Mitochondrial DNA copy number was decreased by 30% in the cortex of PNx rats. In contrast, the
levels of an outer mitochondrial membrane protein, VDAC1, remained unchanged in remnant kidneys.
Mitochondrial biogenesis was not altered after renal mass ablation as was indicated by unchanged levels of PPARγ
and PGC1α proteins. Autophagy related protein Beclin 1 was up-regulated in remnant kidneys, however the level of
LC3-II protein was unchanged. BNIP3 protein, which can initiate both mitochondrial autophagy and cell death, was
up-regulated considerably in kidneys of nephrecomized rats.
Conclusions: The results of the study demonstrated that notable alterations in the renal cortex of 5/6
nephrectomized rats were associated with mitochondrial damage, however mitochondrial biogenesis and
autophagy for replacement of damaged mitochondria were not stimulated. Accumulation of dysfunctional
mitochondria after 5/6 nephrectomy may cause multiple adjustments in biosynthetic pathways, energy production,
ROS signaling, and activation of pro-cell death regulatory pathways thus contributing to the development of
chronic kidney disease.
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Chronic kidney disease (CKD) affects about 10% of pa-
tients worldwide [1]. The disease often develops from acute
kidney injury if normal renal tissue repair is disrupted or
the causes of injury are persistent. Chronic stages of the
disease are marked by progressive kidney remodeling and
fibrosis which, once is initiated, is very difficult to restrain
or reverse. In spite of numerous investigations with various
animal models of CKD, the detailed mechanism of tubular
atrophy coupled with the increased interstitial scarring re-
mains poorly defined [2].
The partially nephrectomized (PNx) rat is a well-
established model for investigation of archetypal patho-
logical changes in CKD. Similar to human disease, the
remnant kidney develops adaptive compensatory growth
several days after injury. The later stages of CKD in
humans and in the rat models are associated with pro-
gressive depletion of tubular and glomerular cells. This
ultimately leads to glomerular obsolescence, tubular at-
rophy, and tubulointerstitial fibrosis [3]. In our study, we
employed a two-dimensional proteomic analysis of kid-
ney cortex tissue from PNx and sham operated rats to
avoid preconceived bias toward any existing hypothesis
of CKD progression. We found that the majority of pro-
teins with altered expression in kidneys of PNx rats were
related to metabolism. We also demonstrated that meta-
bolic alterations in the PNx kidneys were associated with
a significant reduction of mitochondrial DNA and pro-
teins without concomitant changes in mitochondrial bio-
genesis and autophagy.Methods
Animals
All surgical procedures were conducted in accordance
with the National Institute of Health Guide for the Care
and Use of Laboratory Animals using protocol approved
by the University of Toledo Institutional Animal Use and
Care Committee. Two different sets of Male Sprague–
Dawley rats (5 sham operated and 9 PNx in each set)
weighting ~ 250 g were used for proteomic analysis and
western blotting. Five-sixths (5/6) nephrectomy was in-
duced by surgical removal of the right kidney and ligation
of two-thirds of the arterial supply to the left kidney with
silk ligatures as described previously [4]. Animals were
sacrificed at day 28 post surgery.Creatinine and creatinine clearance
At the end of the study 24 h urine samples were
collected. Blood samples were obtained from abdom-
inal aorta immediately after sacrificing. Creatinine levels
were measured calorimetrically with a commercial kit
from Teco Diagnostics (Anaheim, CA) as previously de-
scribed [5].Protein extraction
The renal cortical tissues were separated from medulla
and ground in liquid N2 followed by a sequential extrac-
tion of the renal proteins. The frozen protein powder was
immediately placed into 40 mM Tris base, containing
FOCUS ProteaseArrest protease inhibitors cocktail (G-
Biosciences, Maryland Heights, MO), shaken for 30 min
at 4°C, and then centrifuged at 15 000 g, 4°C for 30 min.
The supernatant was saved as Extract 1. The pellet was
then left to dissolve overnight on a shaker at 4°C in 8 M
Urea, 4% CHAPS, 40 mM Tris base, 0.2% Bio-Lyte 3/10
(Bio-Rad, Hercules, CA) and 2 mM TCEP as a reducing
agent (Pierce, Rockford, IL). The next day, the extraction
mixture was centrifuged at 15 000 g, 4°C for 30 min. The
collected supernatant was saved as Extract 2. The re-
maining pellet was dissolved in 5 M Urea, 2 M Thiourea,
2% CHAPS, 2% SB 3–10, 40 mM Tris and 0.2% Bio-Lyte
for 1 hour at room temperature following centrifugation
at 15 000 g, room temperature for 30 min. The super-
natant was saved as Extract 3.
For Western blotting, the frozen protein powder was
transferred into RIPA buffer, containing 50 mM Tris–
HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 5% so-
dium deoxycholate, 0.1% SDS, and Protease Inhibitors
Cocktail (Sigma, St-Louis, MO).
Protein concentration was measured by Modified Pro-
tein Assay (Bio-Rad).
Two-dimensional gel electrophoresis and
protein identification
17 cm IEF strips with different pI gradients supplied either
from Bio-Rad (Bio-Rad) or (GE HealthCare, Piscataway,
NJ) were used in the study. To decrease variations be-
tween two-dimensional gels we used IEF strips from the
same batch to isofocus proteins from control and PNx
groups and 2–3 strips for each group were run simultan-
eously. Protein extracts were diluted in 300 μl of buffer
containing 8 M Urea, 2% CHAPS, 0.2% Bio-Lyte 3/10
(Bio-Rad, Hercules, CA), 2 mM TCEP and trace amount
of bromphenol blue. The samples were loaded onto the
IEF focusing tray, the IEF strip were put on the loaded
sample and covered with mineral oil. Isoelectric focusing
was run on Protean IEF System (Bio-Rad) for 60,000 V-
Hrs. The strips were equilibrated in reduction buffer
containing 2% SDS, 50 mM Tris–HCl pH8.8, 6 M urea,
39% glycerol, 0.002% bromphenol blue and 1% of DTT for
first 15 min and then in the same buffer but with 2.5% of
iodoacetamide instead of DTT for alkylation for 15 more
minutes. Before transferring to PAGE the strips were
rinsed in the SDS-gel running buffer. Proteins were sepa-
rated using 5-20% w/v gradient PAGE with piperazine
diacrylamine as a crosslinker. The gels were run overnight
with the cooling system setting at 10°C. For analytical pro-
teomics gels a total of 50 μg protein were stained with
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protein variations (Silver Staining Kit, GE HealthCare).
Protein spots for identification with mass-spectroscopy
were subjectively selected based on visible changes of their
amounts on all analytical silver gels (10 gels for every ex-
tract of both groups).
Preparative gels were loaded with a total of 500 μg of
protein and stained with SYPRO Ruby Stain (Bio-Rad).
The level of staining was visually monitored until the se-
lected protein spots were bright enough to cut out. Pro-
teins were in-gel trypsin-digested, extracted, de-salted
and send for analysis at the Tufts University Core facility
(http://tucf.org). Proteins were identified by SEQUEST
search of the rat.fasta database (examples of protein search
are shown in Additional file 1).
Antibodies
The following primary antibodies were used: anti-GRP-75
(1:1000; SPS-825D, Assay Design/Stressgen; Plymouth
Meeting, PA), anti-MCAD (1:4000; A21988; Invitrogen,
Carlsbad, CA), anti-PGK-1 (1:2000; LS-C81162; LifeSpan
BioSciences, Seattle, WA), anti-Beclin 1 (1:1000; 3738; Cell
Signaling Technology, Danvers, MA), anti-BNIP3 (1:500;
ab-65874; Abcam, Cambridge, MA), anti-LC3 (1:1000, NB
100-2220, Novus Biologicals; Littleton, CO), anti-VDAC1
(1:1000; ab15895, Abcam), anti-COXIV (1:1000, ab14744,
MitoSciences, Eugene, OR). The following antibodies were
purchased from Santa-Cruz Biotechnology (Santa-Cruz,
CA): anti-PPARγ (1:500; sc-7273), anti-PGC1α (1:200; sc-
5816) and anti-actin (1:1000: sc-1616) and all peroxidase-
conjugated secondary antibodies.
Western blot analysis and immunohistochemistry
Western blotting and immunohistochemistry were per-
formed as described previously [6]. Briefly, equal amounts
(10–40 μg) of proteins were loaded onto SDS-PAGE
followed transfer to Immobilon-P membrane (Millipore,
Billerica, MA) by semi-dry electroblotting. Membranes
were then air-dried, rewetted in methanol and blocked in
TBS supplemented with 0.1% Tween-20 and 5% non-fat
milk or in 5% BSA for Beclin 1 detection. All primary anti-
bodies were used as suggested by the manufacturer.
Peroxidase-conjugated secondary antibodies were incu-
bated with the blot for one hour at room temperature and
developed using ECL Plus detection reagent (Amersham).
For immunohistochemistry, after deparafinization and
rehydration, 5 μm thick kidney sections were boiled in
acetic buffer (Vector Laboratories, Burlingame, CA, USA)
in a conventional microwave. The endogenous peroxidase
activity was blocked with 3% H2O2 in methanol. The
slides were then washed in TBS, blocked in TBS con-
taining 1.5% goat serum for 45 min at room temperature,
and probed with anti-MCAD or anti-GRP75 antibodies
diluted 1:50 or 1:100 respectively in 1.5% goat serum/BSAin TBS for one hour at room temperature. Finally, the tis-
sue sections were treated according to standard ABC
protocol (Vector Laboratories).
StaRT-PCR for analysis of mitochondrial and nuclear
DNA content
Mitochondrial DNA (mtDNA) content was quantified
by competitive PCR according to the method described
in detail by Willey et al. [7]. Briefly, DNA from whole
kidneys was extracted using DNeasy Tissue Kit (Qiagen,
Germantown, MD). DNA was amplified in an Eppendorff
Thermal Cycler for 35 cycles with primers for mitochon-
drial genes – cytochrome B (F: TAA ACT CCG ACG
CAG ACA AA, R: 5′: GGT GAT TGG GCG GAA TG)
and COXII (F: 5′ GCC CTT CCC TCC CTA C, R: 5′
GAC GTC TTC GGA TGA GAT TA), and actin (R: 5′
GAG CGG ACA CTG GCA AAG, F: 5′ CAA AGA CCC
ATA GGC CAT CA) for nuclear genes. Competitive tem-
plates (CT) were: for cytochrom B – 5′CAA AGA CCC
ATA GGC CAT CAA CAG ATG CGG CTT AAC ACC
C; for COXII -5′GAC GTC TTC GGA TGA GAT TAG
GTT TTA GGT CAT TGG TTG G, and for actin – 5′
CAA AGA CCC ATA GGC CAT CAA CAG ATG CGG
CTT AAC ACC C. 25 μl of PCR reaction contained
20 ng of total DNA, 12.5 μl of PCR master mix (Promega,
Madison, WI), 2 μl of each primers and 1 μ of CT mixture
containing 10-15 moles of mitochondrial templates and
10-11 moles of nuclear templates. Reaction products were
analyzed on Agilent 2100 Bioanalyser Microfluidic CE De-
vice using DNA 1000 LabChip kit (Agilent Technology,
Santa Clara, CA). The native template to competitive tem-
plate ratio was calculated and the number of mitochon-
drial or nuclear DNA molecules was estimated according
to Willey et al. [7].
Statistical analysis
Data are presented as the mean ± standard error of the
mean. Unpaired Student’s t-test was used to evaluate the
difference between two groups. Statistical significance was
reported at the *p < 0.05 and **p < 0.01 levels.
Results
Analysis of 2D proteomic data
Physiological measurements of sham-operated and PNx
rats are summarized in Table 1. Two-dimensional PAGE
revealed in total more than 3000 detectable protein spots
from three sequential protein extracts of the renal cortex
(Figure 1). The six most prominent spots showing consis-
tent differences between sham-operated and PNx samples
were in-gel trypsin digested and identified with matrix–
assisted, laser desorption/ionization time-of-flight mass
spectroscopy (MALDI-TOF). This analysis revealed eight
non-redundant proteins with a high level of confidence
based on percentage of protein coverage, peptide number
Table 1 Physiological measurements of control and
partially nephrectomized rats
Sham (n = 10) PNx (n = 18)
Body weight (g) 458 ± 10 440 ± 9
Kidney weight (g) 1.74 ± 0.09 2.52 ± 0.17**
Plasma creatinine (mg/dL) 0.32 ± 0.05 1.16 ± 0.11**
Creatinine clearance (ml/min) 6.12 ± 0.45 1.06 ± 0.05**
Hematocrit (%) 45 ± 0.9 39 ± 1*
Values represent group mean ± s.e.m. *p < 0.05 and **p < 0.01 vs control group.
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search (Table 2). Two proteins with increased level of ex-
pression in PNx rats were vimentin and albumin (spots 3
and 4 on Figure 1). Vimentin is a cytosketetal protein
which, when expressed, is associated with a mesenchymal
phenotype. Immunohistochemical examination of renal
sections stained with antibody against vimentin confirmed
an increase in vimentin expression in glomerular, intersti-
tial cells, and in arterioles of PNx rats at 28 days post-
surgery as previously reported (Additional file 2: Figure S1)
[8]. Increased albumin accumulation in proximal tubules
and glomeruli of 5/6 nephrectomized rats has also been
reported at this time point [9]. One of the proteins identi-
fied in spot 2, argininosuccinate synthase, was reported asFigure 1 Differentially expressed proteins from renal cortex of sham op
two-dimensional gels run for every protein extract from the control and PNx
(Extract 1) the most prominent spots with decreased levels in cortex of PNx
aginonosuccunate synthase 1 in the spot 2. Protein in spot 3 was identified a
fraction (Extract 2) the most prominent difference between proteins from PN
were identified as albumin (a marker of tubulointerstitial injury) and GRP-75 (a
membrane-bound proteins (Extract 3) of renal cortex, the protein from spotunchanged [10] or decreased [11] in the same PNx model.
Remarkably, the five remaining proteins with decreased
levels of expression are, in different ways, involved in en-
ergy metabolism and mitochondrial functions.
Down-regulation of mitochondrial proteins and DNA in
PNx kidneys
Three out of the five identified metabolism-related pro-
teins - medium chain acetyl dehydrogenase (MCAD),
phosphoglycerate kinase 1 (PGK-1), and glucose regulated
protein-75 (GRP-75) - were used for proteomic data valid-
ation by Western blotting analysis. The difference in total
amounts of PGK-1 protein was not significant between
the two groups (data not shown). We used different sets
of animals for proteomic and western blot studies so lack
of difference in PGK-1 levels between control and PNx
kidneys may be due to subtle difference in experimental
conditions (such as feeding, time of sacrifice). However,
the total levels of MCAD and GRP-75 were significantly
decreased (p < 0.05 and p < 0.01) in the renal cortex of
PNx rats compared to the sham operated controls in
accord with 2D PAGE findings (Figure 2A,B). Since we
were not able to find reliable antibodies against γ-subunit
of ATP-1 synthase, we analyzed expression of another
protein from the oxidative phosphorylation complex,erated and PNx rats. Representative images of 1 from 10
groups. 2-D gels were stained with Silver. A – in cytosolyc fraction
rats were identified as MMSDH in spot 1, and PGK1, MCAD and
s 40 kD fragment of fibrosis marker protein vimentin. B – in hydrophobic
x and sham operated rats were seen in spots 4 and 5. These proteins
mitochondrial chaperone molecule) respectively. C – in the fraction of
6 was identified as gamma subunit of ATP-1 synthase.
Table 2 Renal proteins identified by MALD-TOF mass spectrometry and some parameters used to evaluate SEQUEST search results










value ± SD Rank /Sp ± SD
Ions
(%) ± SD Localization/function
1 Methylmalonate
Semialdehyde dehydrogenase
giI13591997 57770 56.0/56.2 13 3.63 ± 0.93 0.45 ± 0.11 1.23 ± 1.09 67.26 ± 16.52 Mitochondria/ TCA, valine
and pyrimidine metabolism
2 Phosphoglycerate kinase 1 giI1730519 44534 44.6/45.2 15 3.36 ± 1.12 0.32 ± 0.16 1.66 ± 2.09 59.31 ± 17.60 Cytoplasm/glycolysis
2 Acyl-coenzyme-A-
dehydrogenase (medium chain)
giI8392833 46535 39.0/39.0 13 3.44 ± 1.03 0.37 ± 0.14 1.07 ± 0.27 66.61 ± 9.3 Mitochondria/ β-oxidation
2 Arginosuccinate synthetase 1 giI25453414 46467 55.1/55.7 24 3.80 ± 1.22 0.37 ± 0.15 1 ± 0 65.80 ± 21.33 Cytoplasm/urea cycle
3 Vimentin (fragment) giI14389299 53697 50.1/50.0 23 3.53 ± 1.18 0.34 ± 0.11 1.26 ± 1.05 76.11 ± 18.50 Cytoplasm/cytoskeleton
4 Albumin (rat) giI19705431 68674 73.8/73.0 45 3.84 ± 0.79 0.40 ± 0.11 1.06 ± 0.33 71.63 ± 14.14 Plasma/ protein transport
5 Glucose regulated protein 75 giI2119726 73699 53.2/53.1 31 3.97 ± 0.71 0.44 ± 0.11 1 ± 0 72.68 ± 11.90 Mitochondria/chaperon,
structural



















Figure 2 Decrease of mitochondrial proteins and DNA in the rat kidneys after PNx surgery. Representative Western blots (A) and
densitometry analysis (B) shows down regulation of MCAD (n = 6), COXIV (n = 6) and GRP-75 (n = 11) in PNx rats when compared to the sham
operated controls. *p < 0.05, **p < 0.01. C - Sham operated control cortex contains approx. 450 copies of mitochondrial genes COX II and
Cytochrom B per nuclear actin gene. Renal mass ablation PNx results in a decrease of mitochondrial DNA below 300 copies per actin. n ≥ 15,
*p < 0.05, **p < 0.01.
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ting demonstrated that COXIV levels were indeed signifi-
cantly (p < 0.05) reduced in PNx kidneys (Figure 2A,B).
All three down-regulated proteins, MCAD, GRP-75 and
COXIV, are located exclusively in the inner mitochondrial
compartment. In contrast, the amounts of the outer mem-
brane protein VDAC1 (voltage-dependent anion channel 1)
in the PNx kidneys were similar to those in the sham-
operated kidneys.
To further elucidate mitochondrial damage in PNx kid-
neys we examined mitochondrial DNA content. The renal
cortex of sham operated rats contained around 450 copies
of mitochondrial genes cytochrome c oxidase subunit II
and cytochrome b per nuclear actin gene (Figure 2C). In
the cortex of PNx rats the copy number of mitochondrial
genes was reduced to around 300 copies per actin gene.
Immunohistochemical examination of mitochondrial injury
Mitochondrial injury after renal mass ablation was further
examined by immunohistochemistry (Figure 3). In sham-operated rats an intensive specific staining with both anti-
MCAD and anti-GRP-75 antibodies was clearly visible in
the tubular compartment of the cortex reflecting high
mitochondrial density in tubular epithelial cells. In glom-
erular cells, the levels of MCAD and GRP-75 proteins
were below the detectable threshold. Microphotographs of
immunohistochemical staining of the cortical sections
from PNx rats showed that epithelial cells in some tubules
contain high levels of MCAD and GRP-75 while in flat-
tened epithelial cells abundance of these proteins was not-
ably decreased. Therefore, mitochondrial injury was not
evenly distributed throughout the cortical tissue in PNx
kidenys. Tubules with low mitochondrial density were as-
sociated with areas of interstitial inflammation and fibrosis
(Figure 3).
Mitochondrial biogenesis and autophagy after PNx
Mitochondrial abundance is determined by a balance be-
tween their synthesis and degradation. As shown by
Western blotting, the expression levels of two essential
Figure 3 Representative microphotographs of immunohistochemical examination of renal cortical sections from sham operated and
PNx rats. In sham-operated control kidneys the specific staining for both mitochondrial proteins – MCAD and GRP-75 - is distributed evenly
throughout the cortical tissue. After PNx, many tubules (especially in fibrotic and inflamed lesions) showed a marked decrease in expression of
mitochondrial MCAD and GRP-75 proteins. Bar = 100 μm. The images were taken on a Nikon Eclipse 80i microscope equipped with a Nikon
camera HeadDS-Fi1 (Nikon, Tokyo, Japan).
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co-activator PGC-1α [12] were not significantly altered
in the cortex of PNx rats (Figure 4A,B).
Damaged mitochondria are eliminated by a specific
type of selective mitochondrial autophagy [13,14]. This
process is initiated by formation of a double-membrane
organelle known as the autophagosome. The Beclin 1
protein is essential for early stages of autophagosome
membrane formation [15]. BCL2/adenovirus E1B 19 kDa
interating protein 3 (BNIP3) is involved specifically in
mitochondrial autophagy either by induction of Beclin 1
levels or by a specific targeting of damaged mitochondria to
the autophagosome [16-18]. Both Beclin 1 and BNIP3 pro-
teins were significantly up-regulated (p < 0.05) in the PNx
kidneys when compared to the sham-operated controls
(Figure 4A,B). Later stages of autophagy - autophagosome
maturation and closure - are critically dependent on the
lipid-conjugated form of LC3 (microtubule-associated
protein 1 light chain 3) protein [19]. Both cytoplasmic
(LC3-I) and autophagosome-bound lipidated (LC3-II)
forms were present in kidneys of sham-operated and
PNx rats (Figure 4C). Although the LC3-II levels were de-
creased in PNx kidneys this difference was not statisticallysignificant (Figure 4D). SQSTM1/sequristome/p62 protein
or p62, an ubiquitin-binding protein, is a selective substrate
of autophagy and an accumulation of both p62 and
ubiquinated proteins serves as an indicator of autophagy in-
hibition [20-22]. p62 band was not detected by Western
blot with exception of one animal which also had a slight
increase in abundance of ubiquinated proteins and a very
low level of LC3-II (Additional file 3: Figure S2).
Discussion
PNx model
Renal mass ablation in PNx rats leads to adaptive hyper-
trophic growth of the remaining kidney within 7–10 days
post-surgery [23]. This growth is accompanied by the
development of glomerular sclerosis, hypertensive vascu-
lar changes, and tubular atrophy. However, after the fourth
week post-surgery, the PNx kidney is characterized by
marked retardation of compensatory renal growth, a pro-
gressive increase in accumulation of apoptotic cells in
every renal cell population, and augmented tubular–inter-
stitial injury and fibrosis [24,25]. We attempted to eluci-
date major alterations in the cortical proteome associated
with progress to the chronic stage of renal disease at that
Figure 4 Mitochondrial biogenensis and autophagy in the cortical tissue of PNx rats. Representative immunoblot (A) and densitometry
analysis (B) of expression of proteins controlling mitochondrial biogenesis – PGC1α and PPARγ (A,B). No significant changes were found. n = 10.
Representative western blots (C) and densitometry analysis (D) of Beclin 1 and BNIP3 demonstrate significant up-regulation of these proteins in
PNx kidneys when compared with sham-operated controls. Note two forms of LC3: slowly moving cytoplasmic LC3-I, and more mobile lipidated
form of LC3-II (A). n = 8, *p < 0.05.
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proteomics (variations in IEF strips, complexity of protein
patterns on the gel, low sensitivity for less abundant regu-
latory proteins), we identified eight proteins with altered
abundance which are associated with three biochemical
features of PNx kidneys – i) albumin accumulation, ii) up-
regulation of vimentin reflecting an acquisition of a more
mesenchymal phenotype by variety of renal cells, iii) and
metabolic perturbations. While albumin toxicity and glom-
erular damage/fibrogenesis have been recently studied in
this model [9,26], metabolic alterations specific for PNx
kidneys gained much less attention since its first recogni-
tion two decades ago [27-30].
Hypertrophic growth of PNx kidneys is accompanied
by considerable alterations of the metabolic state of the
remaining nephrons (called also hypermetabolism of the
remnant kidney) manifested by an increased net glucose
production [30], accumulation of inorganic phosphate [28],
and inefficient oxygen utilization per nephron and per
sodium transport [27-29]. In response to compensatory
hypertrophy, all nephron segments become enlarged. How-
ever, the proximal tubules grow out of proportion to the
rest of the nephron [24,25]. In proximal tubules mitochon-
dria occupy from 22 to 39% (depending of the segment) of
the cellular volume [31]. With low capacity for anaerobic
glycolysis [32], the adaptation of proximal tubules in rem-
nant kidneys for increased demand in ATP production(needed for electrolyte transport) relies on alterations in
the structure and abundance of their mitochondria. Ac-
cordingly, at acute stages of renal growth after renal mass
ablation (up to 2 weeks) mitochondrial proliferation/hyper-
trophy has been reported [33,34]. However, early investiga-
tions showed that renal mitochondria become uncoupled
at 4 weeks post-surgery with trends toward a decrease in
ATP production and total oxygen consumption [27,29].
Taken together, these observations are in line with our
present data which showed perturbations in renal mito-
chondria at this stage.Mitochondrial damage in PNx kidneys
Mitochondrial proteins and DNA, which we found to be
depleted in the kidneys of PNx rats, are located to the
inner mitochondrial compartment. GRP-75 is located
largely to the inner mitochondrial membrane but also
can be found in other sub-cellular sites [35,36]. Consid-
ering high mitochondrial density of the renal proximal
epithelial cells [31], we assume that GRP-75 protein from
the examined cortical extract represents largely its mito-
chondrial fraction. MCAD, a key enzyme of mitochondrial
β-oxidation of fatty acids, and COXIV are both localized
exclusively to the mitochondrial matrix and inner mito-
chondrial membrane respectively. In contrast, the levels
of VDAC1 protein, which is ubiquitously situated on the
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PNx kidneys
Decrease in mitochondrial proteins abundance in the
PNx kidney was distributed heterogeneously throughout
the cortex as demonstrated by immunohistochemical ana-
lysis of GRP-75 and MCAD (Figure 3). Weak immuno-
staining for inner mitochondrial proteins was observed
only in the flattened epithelial cells of dilated tubules,
which were surrounded by enlarged interstitum. Thus, the
areas with damaged mitochondria may be associated with
poor tubulointerstitial reperfusion and hypoxia as conse-
quences of the distortion and collapse of the peritubular
capillaries seen in PNx kidneys from the second week on-
ward [37-39]. The hypoxic milieu stimulates secretion of
profibrotic signals from tubular, interstitial and endothelial
cells resulting in accumulation of fibrotic tissue [40]. In
turn, fibrotic scar formation results in extension of the
distance between existing capillaries and tubular cells thus
reducing the efficiency of oxygen diffusion. Thus through
this cycle of pathological amplification, the portion of is-
chemic tubules progressively increases [40].
The mitochondrial membrane potential is especially
low in proximal tubules and collapses easily under hyp-
oxia [41]. Ischemic insult to renal epithelial cells causes
considerable damage to the mitochondrial inner mem-
brane and leads to mitochondrial swelling and disrup-
tion of cristae structure [42]. In our parallel investigation
of the ischemic 2 Kidneys 1 Clip model of renal stenosis,
we also found considerable decrease in abundance of
inner mitochondrial proteins with unchanged levels of
VDAC1 [43].
Autophagy in PNx kidneys and in CKD
Damaged mitochondria are a major source of genotoxic
oxidant species and pro-death factors. Therefore, mito-
chondrial quality control is crucial for renal cell survival.
Autophagy, a process by which the entire damaged or-
ganelle, including a mitochondrion is eliminated, requires
formation of a special double-membrane structure called
an autophagosome. The lipidated form of the LC3 protein,
LC3-II, which essential for autophagosomal-lysosomal
fusion, is a commonly used molecular marker of auto-
phagosome maturation. Total LC-II amount is an indica-
tor of two intracellular activities: i) the level of autophagic
flux; and ii) the rate of LC3-II lysosomal degradation
[44,45]. In order to distinguish between these two activ-
ities in vitro, specific inhibitors of lysosomal proteases are
commonly used. However, this method is hard to use
in vivo [45]. Another commonly used marker of autoph-
agy is SQSTM1/sequristome/p62 protein. Yet p62 levels
are regulated by several pathways independent of autoph-
agy [46,47]. In PNx extracts the levels of LC3-II isoform
was not significantly decreased when compared to con-
trols (Figure 4) and p62 was not detected by Western blotwith the exception of one animal which also had a very
low level of LC3-II on Western blots (Additional file 3:
Figure S2). Thus, the trend to reduction of LC3-II accu-
mulation in combination with unchanged levels of outer
mitochondrial membrane protein VDAC1 suggests that
autophagy is not likely to be activated in PNx kidneys and
thus unlikely to be responsible for reduction in mitochon-
drial proteins. In the 2 kidneys 1 clip model we did not de-
tect either LC3-II or ATG5 (the protein required for LC3
lipidation) by Western blot yet this model was associated
with marked p62 accumulation [43]. Although autophagy
stimulation in response to multiple acute kidney injuries
has been shown to be protective [48,49], autophagy is
seemingly inhibited during prolonged cellular stress and
in aged kidney [50-52]. In a cisplatin-induced model of
renal deficiency, the autophagic flux is gradually decreased
and activation of autophagy during the course of cisplatin
toxicity exacerbates kidney injury [53]. Finally, persistently
increased autophagy in patients with genetic nephropathic
cystinosis has been linked to renal cell injury and apop-
tosis, and autophagy inhibition has been found to be
cytoprotective [54].
Autophagy has been linked with negative regulation of
apoptosis [55]. The crosstalk between autophagy and
apoptosis is mediated by complex interactions between
Bcl-2 proteins. Two members of this family, BH3-only
proteins Beclin 1 and BNIP3, were up-regulated in the
PNx kidneys (Figure 4). The role of Beclin 1, an impor-
tant inducer of autophagosome membrane formation, in
regulation of apoptosis is not fully understood [56]. Expres-
sion of the BNIP3 protein is specifically up-regulated by
hypoxia [57,58]. BNIP3 is primarily localized in the mito-
chondrial membrane [59] but has also recently been found
on the endoplasmic reticulum [60]. Under stress condition
BNIP3 binds directly to LC3-II through its LC3-interacting
region thus delivering target damaged organelles for au-
tophagic degradation [60]. In hypoxic aged kidneys, BNIP3
activation by caloric restriction promotes mitochondrial
autophagy and thus enhances kidney adaptation to hypoxia
[50]. However, BNIP3 functions are context-dependent
and autophagy induction and cell-death promotion are
shown to be two separate activities of BNIP3 [17,18,59,61].
As we found in PNx kidneys, autophagy is not likely to be
up-regulated, thus BNIP3 autophagic activities may be lim-
ited (Figure 4). When autophagy is inhibited, BNIP3 in-
duces swelling of inner mitochondrial membranes and
triggers release of pro-apoptotic proteins [62]. Notably, a
drastic increase in apoptosis of tubular epithelial begins
from 4 weeks after surgery in the PNx models [63]. In
addition to apoptosis and autophagy, mitochondria-bound
BNIP3 forms a complex with NIX and Mieap proteins,
which mediates translocation of lysosomal proteins into the
mitochondrial matrix. Through such a mechanism BNIP3
controls elimination of oxidized mitochondrial proteins as
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regulation of mitochondrial proteins located in the inner
mitochondrial compartments (Figure 2A) suggests that this
particular mechanism may be activated by BNIP3 in PNx
kidneys. BNIP3 protein involvement in mitochondrial turn-
over and cell death has been mostly studied in the myocar-
dium [57,59,61,66,67] and in multiple cancer cell lines
[17,68,69]. We have recently demonstrated that renal ne-
crosis in the Goldblatt’s 2 kidneys, 1 clip model was
associated with up-regulation and activation of BNIP3
protein [43]. Specifically, reduction of oxidative stress
by activation of PPARδ signaling resulted in BNIP3 de-
activation, preservation of mitochondrial function, and
prevention of cell death.
Conclusion
In conclusion, we found mitochondrial impairment in PNx
kidneys and an up-regulation of BNIP3, a key protein in
regulation of both mitochondrial quality control and cell
death in PNx kidneys. These findings together with our ob-
servations in Goldblatt’s 2 kidneys, 1 clip model, suggests
that BNIP3 protein may play an important role coordinat-
ing the intricate relationship between mitochondrial health,
autophagy, and cell-death regulatory pathways in the devel-
opment of CKD.
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